Barbados - Re-Export of Heparin for Therapeutic Use
Since 2014, Barbados Re-Export of Heparin for Therapeutic Use rose 14.6% year on year. In 2019, the country was ranked number 3 among other countries in Re-Export of Heparin for Therapeutic Use at $212,328.1. Barbados is overtaken by Canada, which was number 2 at $728,579.06 and is followed by Saudi Arabia at $173,620.88. United States ranked the highest with $4,598,060.57 in 2019, that is -5.2% compared to 2018. New Zealand witnessed the best average annual growth at +141.8% per year, while United States witnessed the worst performance at -29.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 212,328.10 |
| 2018 | 189,608.50 |
| 2017 | 236,816.00 |
| 2016 | 126,286.00 |
| 2015 | 155,424.00 |
Download all data from 1997 to 2019
How does Barbados rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data |
| 3 |
#3
Barbados
|
212,328.10 | 2019 | +12.0 % | +14.6 % | View data |
| 4 |
#4
Saudi Arabia
|
173,620.88 | 2016 | -45.1 % | NA | View data |
| 5 |
#5
Jordan
|
114,511.44 | 2019 | -6.3 % | -22.7 % | View data |